Ping Xuan

Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs

Expanding the molecular language of protein liquid–liquid phase separation

In SilicoPrediction of Gamma-Aminobutyric Acid Type-A Receptors Using Novel Machine-Learning-Based SVM and GBDT Approaches

Prediction of potential disease-associated microRNAs based on random walk